Literature DB >> 9196199

PCR-single-stranded confirmational polymorphism analysis for non-culture-based subtyping of meningococcal strains in clinical specimens.

J Newcombe1, S Dyer, L Blackman, K Cartwright, W H Palmer, J McFadden, L Blackwell.   

Abstract

Subspecific typing of clinical meningococcal strains is important in the investigation of outbreaks and for disease surveillance. Serogrouping, typing, and subtyping of strains currently require isolation of a meningococcus from one or more clinical specimens. However, the increasing widespread practice of preadmission administration of parenteral antibiotics has resulted in a decrease in the frequency of positive cultures obtained from blood and cerebrospinal fluid. Confirmation of meningococcal disease can be obtained by meningococcus-specific PCR from both cerebrospinal fluid (H. Ni et al., Lancet 340:1432-1434, 1992) and peripheral blood (J. Newcombe et al., J. Clin. Microbiol. 34:1637-1640, 1996) specimens. However, current PCR protocols do not yield epidemiologically useful typing information. We report here the use of PCR-single-stranded confirmational polymorphism (PCR-SSCP) analysis to amplify and type meningococcal DNA present in clinical specimens. PCR-SSCP analysis with the VR1 region of the Neisseria meningitidis porA gene as the target produced unique banding patterns for each serosubtype. Direct PCR-SSCP of clinical specimens can therefore provide typing data that can be used to investigate the epidemiology of clusters of cases and outbreaks and for disease surveillance in situations in which culture of patient specimens proves negative.

Entities:  

Mesh:

Year:  1997        PMID: 9196199      PMCID: PMC229847          DOI: 10.1128/jcm.35.7.1809-1812.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Simplified procedures for detection of amplified DNA using fluorescent label incorporation and reverse probing.

Authors:  A J Woolford; J W Dale
Journal:  FEMS Microbiol Lett       Date:  1992-12-01       Impact factor: 2.742

2.  Characterization of serogroup A Neisseria meningitidis strains by rRNA gene restriction patterns and PCR: correlation with the results of serotyping, subtyping and multilocus enzyme electrophoresis.

Authors:  J Auriol; J L Guesdon; M Guibourdenche; J Y Riou
Journal:  FEMS Immunol Med Microbiol       Date:  1995-02

3.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

4.  The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation.

Authors:  J Suker; I M Feavers; M Achtman; G Morelli; J F Wang; M C Maiden
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

5.  PCR of peripheral blood for diagnosis of meningococcal disease.

Authors:  J Newcombe; K Cartwright; W H Palmer; J McFadden
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  PCR amplicon restriction endonuclease analysis of the chromosomal dhps gene of Neisseria meningitidis: a method for studying spread of the disease-causing strain in contacts of patients with meningococcal disease.

Authors:  B E Kristiansen; C Fermér; A Jenkins; E Ask; G Swedberg; O Sköld
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Typing Neisseria meningitidis by analysis of restriction fragment length polymorphisms in the gene encoding the class 1 outer membrane protein: application to assessment of epidemics throughout the last 4 decades in China.

Authors:  P Zhu; X Hu; L Xu
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Design and characterization of PCR primers for detection of pathogenic Neisseriae.

Authors:  B Muralidhar; C R Steinman
Journal:  Mol Cell Probes       Date:  1994-02       Impact factor: 2.365

9.  Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.

Authors:  L G Milagres; S R Ramos; C T Sacchi; C E Melles; V S Vieira; H Sato; G S Brito; J C Moraes; C E Frasch
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy.

Authors:  P Rådström; A Bäckman; N Qian; P Kragsbjerg; C Påhlson; P Olcén
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

View more
  4 in total

Review 1.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

2.  Clonal distribution of invasive Neisseria meningitidis isolates from the Norwegian county of Telemark, 1987 to 1995.

Authors:  R K Aakre; A Jenkins; B E Kristiansen; L O Froholm
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 3.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children.

Authors:  Penelope A Bryant; Hua Yi Li; Angelo Zaia; Julia Griffith; Geoff Hogg; Nigel Curtis; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.